Pricing Log in Create free account

Cibus, Inc. (CBUS) vs Neumora Therapeutics, Inc. (NMRA)

Cibus, Inc. and Neumora Therapeutics, Inc. are both Biotechnology companies. Cibus, Inc. and Neumora Therapeutics, Inc. are of similar size ($91.5M and $87.1M). Neumora Therapeutics, Inc. has the higher net margin (0.00% vs −2,258.9%) and the higher return on invested capital (0.00% vs 0.00%). Across the 13 metrics below, Cibus, Inc. leads on 7 and Neumora Therapeutics, Inc. on 6.

Valuation

Metric CBUS NMRA Biotechnology median
P/E n/m n/m 10.60
P/S 20.66 n/m 9.40
P/B 6.07 2.04 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 16.20 n/m 9.02
Earnings yield (141.03%) (251.02%) (32.88%)
Free cash flow yield (51.53%) (198.74%) (23.13%)

Profitability

Metric CBUS NMRA Biotechnology median
Gross margin 100.00% 0.00% 68.51%
Operating margin (1,450.59%) 0.00% 0.00%
Net margin (2,258.89%) 0.00% 0.00%
Free cash flow margin (1,064.60%) 0.00% 0.00%
Return on equity (219.97%) (187.11%) (51.96%)
Return on assets (29.77%) (121.89%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CBUS NMRA Biotechnology median
Revenue growth (TTM) (10.30%) — 6.76%
EPS growth (last fiscal year) 74.33% 5.23% 29.88%
Revenue growth, 5-year CAGR (31.34%) — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric CBUS NMRA Biotechnology median
Debt to equity 0.00 1.19 0.00
Current ratio 1.62 4.50 4.97
Net debt to EBITDA (0.28) 0.53 1.01

Dividend

Metric CBUS NMRA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CBUS NMRA Biotechnology median
Market cap 87.13m 91.51m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack